Department of Cardiothoracic Surgery at New York Presbyterian, Weill Cornell Medicine, New York.
Division of Cardiothoracic Surgery, University of North Carolina, Chapel Hill, USA.
Int J Surg. 2024 Sep 1;110(9):5795-5801. doi: 10.1097/JS9.0000000000001765.
Postoperative bleeding requiring re-exploration is a serious complication that occurs in 2.8-4.6% of patients undergoing cardiac surgery. Re-exploration has previously been associated with a higher risk of short-term mortality. However, a comprehensive analysis of long-term outcomes after re-exploration for bleeding has not been published.
The authors performed a systematic, three databases search to identify studies reporting long-term outcomes in patients who required re-exploration for bleeding after cardiac surgery compared to patients who did not, with at least 1-year of follow-up. Long-term survival was the primary outcome. Secondary outcomes were operative mortality, myocardial infarction, stroke, renal and respiratory complications, and hospital length of stay. Random-effects models was used. Individual patient survival data was extracted from available survival curves and reconstructed using restricted mean survival time.
Six studies totaling 135 456 patients were included. The average follow-up was 5.5 years. In the individual patient data, patients who required re-exploration had a significantly higher risk of death compared with patients who did not [hazard ratio (HR): 1.21; 95% CI: 1.14-1.27; P <0.001], which was confirmed by the study-level survival analysis (HR: 1.32; 95% CI: 1.12-1.56; P <0.01). Re-exploration was also associated with a higher risk of operative mortality [odds ratio (OR): 5.25, 95% CI: 4.74-5.82, P <0.0001], stroke (OR: 2.05, 95% CI: 1.72-2.43, P <0.0001), renal (OR: 4.13, 95% CI: 3.43-4.39 P <0.0001) respiratory complications (OR: 3.91, 95% CI: 2.96-5.17, P <0.0001), longer hospital length of stay (mean difference: 2.69, 95% CI: 1.68-3.69, P <0.0001), and myocardial infarction (OR: 1.85, 95% CI: 1.30-2.65, P =0.0007).
Postoperative bleeding requiring re-exploration is associated with lower long-term survival and increased risk of short-term adverse events including operative mortality, stroke, renal and respiratory complications, and longer hospital length of stay. To improve both short-term and long-term outcomes, strategies to prevent the need for re-exploration are necessary.
心脏手术后需要再次探查的术后出血是一种严重的并发症,发生率为 2.8-4.6%。既往研究表明,再次探查与短期死亡率升高相关。然而,关于再次探查治疗出血的长期结局尚未见全面分析。
作者进行了系统的、三个数据库的检索,以确定报告心脏手术后因出血需要再次探查的患者与未进行再次探查的患者的长期结局的研究,随访时间至少为 1 年。主要结局为长期生存。次要结局为手术死亡率、心肌梗死、卒中和肾、呼吸系统并发症以及住院时间。使用随机效应模型。从可用生存曲线中提取个体患者的生存数据,并使用受限平均生存时间进行重建。
纳入 6 项总计 135456 例患者的研究。平均随访时间为 5.5 年。在个体患者数据中,需要再次探查的患者的死亡风险明显高于未进行再次探查的患者[风险比(HR):1.21;95%置信区间(CI):1.14-1.27;P<0.001],研究水平的生存分析也证实了这一结果(HR:1.32;95%CI:1.12-1.56;P<0.01)。再次探查还与手术死亡率增加相关[比值比(OR):5.25;95%CI:4.74-5.82;P<0.0001]、卒中和(OR:2.05;95%CI:1.72-2.43;P<0.0001)、肾脏(OR:4.13;95%CI:3.43-4.39;P<0.0001)和呼吸系统并发症(OR:3.91;95%CI:2.96-5.17;P<0.0001)、住院时间延长(平均差异:2.69;95%CI:1.68-3.69;P<0.0001)和心肌梗死(OR:1.85;95%CI:1.30-2.65;P=0.0007)有关。
需要再次探查的术后出血与长期生存降低和短期不良事件风险增加相关,包括手术死亡率、卒中和肾、呼吸系统并发症以及住院时间延长。为了改善短期和长期结局,有必要制定预防再次探查的策略。